Danielle Zerr is an Infectious Disease physician affiliated with Seattle Children's Hospital. OpenAlex indexes 272 publications with 8,487 citations (h-index 51); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Fecal Microbiota Transplantation as a Strategy to Eradicate Resistant Organisms
Sponsor: Seattle Children's Hospital
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
NIH funding
6 NIH research awards on record, funded 1999–2017 per NIH RePORTER. The latest:
- Impact of chlorhexidine bathing on reducing infections in children with cancer
Seattle Children'S Hospital
FY2017$179,792R01CA163394 - Impact of chlorhexidine bathing on reducing infections in children with cancer
Seattle Children'S Hospital
FY2016$542,687R01CA163394 - Impact of chlorhexidine bathing on reducing infections in children with cancer
Seattle Children'S Hospital
FY2015$171,762R01CA163394
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Interim Estimates of 2024–2025 Seasonal Influenza Vaccine Effectiveness — Four Vaccine Effectiveness Networks, United States, October 2024–February 2025
MMWR Morbidity and Mortality Weekly Report
2025 - Interim Estimates of 2023–24 Seasonal Influenza Vaccine Effectiveness — United States
MMWR Morbidity and Mortality Weekly Report
2024 - Notes from the Field: Reemergence of Mycoplasma pneumoniae Infections in Children and Adolescents After the COVID-19 Pandemic, United States, 2018–2024
MMWR Morbidity and Mortality Weekly Report
2024 - Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024
Archives of Pediatrics and Adolescent Medicine
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Margaret Rosenfeld, MD, MPH
Seattle Children's Hospital
Michael Portman, MD
Seattle Children's Hospital
Douglas Hawkins
Seattle Children's Hospital
Christopher Blosser, MD
Seattle Children's Hospital
Yousef Khader
Jordan University of Science and Technology
Thomas Walsh, MD
Cornell University
Vance Fowler, MD
Duke University
Derrick W. Crook
Nuffield Orthopaedic Centre
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”